Stryker Corporation
No price chart data available for 1D timeframe.
Rating
Why Price Moved
Shares are down after Stryker reported Q3 earnings...
Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implan...
Latest News
2 days ago · zacks.com
SYK Stock Skids as Q3 Earnings and Sales Miss & 2026 Outlook CutStryker shares plunge 11.8% after Q3 earnings and sales miss estimates, prompting a 2026 outlook cut amid weak joint procedures and execution challenges.
2 days ago · prnewswire.com
Stryker (NYSE: SYK) Scrutinized Amid Disclosure of Persisting Peripheral Vascular Problems -- HBSSSAN FRANCISCO, Oct. 30, 2026 /PRNewswire/ -- On September 8, 2026, investors in Stryker Corporation (NYSE: SYK) saw the price of their shares fall $26.70 (-8.8%) after the company's CFO revealed that a previously-thought resolved manufacturing issue persists. The move lower wiped out over $10 billion of Stryker's market capitalization.
3 days ago · zacks.com
SYK Q3 Earnings Call Highlights Softer Demand and Revised OutlookStryker cuts its 2026 outlook amid weaker joint replacement demand and supply disruptions, despite MedSurg strength, margin gains and robotics investments.
3 days ago · marketbeat.com
What Stryker (SYK) Said on Its Q3 Earnings CallStryker NYSE: SYK reported third-quarter organic sales growth of 7.7% and adjusted earnings per share of $3.52, while lowering its full-year outlook to reflect a slowdown in hip and knee procedures, lingering peripheral vascular supply constraints and execution risks tied to capital equipment sales.
3 days ago · benzinga.com
Stryker Analysts Cut Their Forecasts Following Downbeat Q3 EarningsStryker Corp. (NYSE:SYK) on Thursday posted weaker-than-expected third-quarter results.
3 days ago · 247wallst.com
Stryker's Guidance Cut Rattles Investors: What It Really Says About 2027Medical device maker Stryker (NYSE:SYK | SYK Price Prediction) shares fell about 10% before the open Friday to $279.98, compared with Thursday's close of $311.75. The quarter missed expectations on both lines.
3 days ago · seekingalpha.com
Stryker Corporation (SYK) Q3 2026 Earnings Call TranscriptStryker Corporation (SYK) Q3 2026 Earnings Call Transcript
3 days ago · zacks.com
Stryker (SYK) Q3 Earnings: Taking a Look at Key Metrics Versus EstimatesAlthough the revenue and EPS for Stryker (SYK) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
3 days ago · zacks.com
Stryker (SYK) Q3 Earnings and Revenues Lag EstimatesStryker (SYK) came out with quarterly earnings of $3.52 per share, missing the Zacks Consensus Estimate of $3.56 per share. This compares to earnings of $3.19 per share a year ago.
3 days ago · benzinga.com
Stryker Q3 2026 Earnings Call TranscriptStryker (NYSE:SYK) reported third-quarter financial results on Thursday. The transcript from the company's third-quarter earnings call has been provided below.
Earnings
Analyst Summary
Add to Watchlist
Select watchlists to add or remove SYK